MetaADEDB 2.0 @ LMMD
Precancerous skin lesion
(UMLS:C0877510)
UMLS ID:
C0877510
MeSH ID:
N/A
Synonym(s)
1.
Precancerous skin lesion
2.
Cutaneous Precancerous Condition
3.
Cutaneous Premalignant Condition
4.
PREMALIGNANT DERMATOSIS
5.
Precancerous Dermatosis
6.
Precancerous Skin Lesion
7.
precancerous dermatosis
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1LenalidomideFAERS: 11US FAERS
2Fingolimod HydrochlorideFAERS: 9US FAERS
3tofacitinibFAERS: 7US FAERS
4Estrogens, Conjugated (USP)FAERS: 5OFFSIDES
US FAERS
5PCI 32765FAERS: 5US FAERS
6AllopurinolFAERS: 3US FAERS
7Azelaic acidFAERS: 3US FAERS
8Dimethyl FumarateFAERS: 3US FAERS
9MetforminFAERS: 3US FAERS
10MetoprololFAERS: 3US FAERS
11Ruxolitinib phosphateFAERS: 3US FAERS
12apremilastFAERS: 3US FAERS
13teriflunomideFAERS: 3US FAERS
14Aspirin-oxycodone hydrochloride-oxycodone terephthalate combinationFAERS: 2US FAERS
15BisoprololFAERS: 2US FAERS
16BosentanFAERS: 2US FAERS
17DabigatranFAERS: 2US FAERS
18DronedaroneFAERS: 2US FAERS
19EnalaprilFAERS: 2US FAERS
20Glatiramer AcetateFAERS: 2US FAERS
21Imatinib MesylateFAERS: 2US FAERS
22ImiquimodFAERS: 2US FAERS
23MethotrexateFAERS: 2US FAERS
24RamiprilFAERS: 2US FAERS
25SorafenibFAERS: 2US FAERS
26TeriparatideFAERS: 2US FAERS
27VoriconazoleFAERS: 2US FAERS
28ambrisentanFAERS: 2US FAERS
29carbidopa, levodopa drug combinationFAERS: 2US FAERS
30pomalidomideFAERS: 2US FAERS
31sibutramineFAERS: 2US FAERS
323-ingenyl angelateFAERS: 1US FAERS
334-hydroxybutyric acidFAERS: 1US FAERS
34AcitretinFAERS: 1US FAERS
35AlendronateFAERS: 1US FAERS
36ArthrotecFAERS: 1US FAERS
37CelecoxibFAERS: 1US FAERS
38CiprofloxacinFAERS: 1US FAERS
39HydroxyureaFAERS: 1US FAERS
40Insulin GlargineFAERS: 1US FAERS
41LCZ 696FAERS: 1US FAERS
42LansoprazoleFAERS: 1US FAERS
43LeflunomideFAERS: 1OFFSIDES
US FAERS
44LiraglutideFAERS: 1US FAERS
45MesalamineFAERS: 1US FAERS
46MetforminFAERS: 1US FAERS
47MethotrexateFAERS: 1US FAERS
48MetronidazoleFAERS: 1US FAERS
49NorgestrelFAERS: 1US FAERS
50OlanzapineFAERS: 1US FAERS
51OmeprazoleFAERS: 1US FAERS
52PramipexoleFAERS: 1US FAERS
53PregabalinFAERS: 1US FAERS
54PropranololFAERS: 1US FAERS
55RanolazineFAERS: 1US FAERS
56RivaroxabanFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
57RivastigmineFAERS: 1US FAERS
58SertralineFAERS: 1US FAERS
59SulfamethoxazoleFAERS: 1US FAERS
60TacrolimusFAERS: 1US FAERS
61TretinoinFAERS: 1US FAERS
62ValsartanFAERS: 1US FAERS
63VemurafenibFAERS: 1US FAERS
64Zoledronic AcidFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
65apixabanFAERS: 1US FAERS
66homosalateFAERS: 1US FAERS
67icatibantFAERS: 1US FAERS
68macitentanFAERS: 1US FAERS
69teduglutideFAERS: 1US FAERS
70valdecoxibFAERS: 1OFFSIDES
US FAERS
71CapecitabineOFFSIDES
72EstradiolOFFSIDES
73FluocinonideOFFSIDES
74HydralazineOFFSIDES
75HydrocortisoneOFFSIDES
76MercaptopurineCanada Vigilance: 1Canada Vigilance
77RibavirinOFFSIDES
78SulindacOFFSIDES
79TerazosinOFFSIDES
80carbidopa, levodopa drug combinationOFFSIDES
81sibutramineOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.